Therefore, Putian Pharmacy, as the sales agency, will be allowed to sell Huoliyuan capsules in 15 Chinese provinces, which indicates that the sales network of Huoliyuan capsules has captured all provincial markets in China by expanding market share as well as increasing unit sales.
CYIG is a biotechnology company, mainly focused on producing medicines and selling organic healthcare products.
It is also dedicated to laying a solid foundation for building a nationwide sales and marketing network. Additionally, CYIG will be offering more incentives to strategic partners to encourage them to create more value for CYIG.
Mr. Xuzhong Ding, the director of marketing and sales for CYIG, said, "Reaching the agreement with Putian Pharmacy accelerates the market development in South-West China, which then pushes CYIG into the entire Chinese market and lays a solid foundation for meeting a pre-determined sales target. Finally, I hope that our cooperation will lead to a better future."